Provenance du réseau au premier degré de Matt Hoberman
Entité | Type d'entité | Industrie | |
---|---|---|---|
Lirum Therapeutics, Inc.
Lirum Therapeutics, Inc. BiotechnologyHealth Technology Lirum Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the treatment of deliberating diseases. The firm is also involved in the acquisition, development, and commercialization of drug candidates. Its products include LX-101, a targeted therapy directed to the insulin-like growth factor 1 (IGF-1R). The company was founded in November 2021 and is headquartered in New York, NY.
5
| Holding Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Matt Hoberman via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Director/Board Member | |
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ACCESS Oncology, Inc.
ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Director/Board Member Director/Board Member | |
University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
Boston University | College/University | Undergraduate Degree | |
State University of New York at Albany | College/University | Undergraduate Degree | |
Supreme Court of the United States | General Government | Corporate Officer/Principal | |
Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services New York State Bar Association is a non-profit organization, which provides legal services and offers a membership program for lawyers. It also publishes an array of books, bar journals, law digest, and State Bar news. The company was founded in 1876 and is headquartered in Alban, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nitron Advisors
Nitron Advisors Investment ManagersFinance Nitron Advisors operates an investment research company. The private company is based in Saratoga, CA. | Investment Managers | Corporate Officer/Principal | |
Kirby Mcinerney LLP
Kirby Mcinerney LLP Miscellaneous Commercial ServicesCommercial Services Kirby McInerney LLP is a plaintiffs' law firm based in the United States that specializes in complex financial litigation and dispute resolution for institutional and individual clients. The private company is based in New York, NY. The company's areas of focus include securities, antitrust, whistleblower, and consumer litigation, among others. The firm has a successful track record in securities litigation, having recovered billions of dollars for shareholders. Kirby McInerney's website provides additional information about the firm. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Columbia Law School | College/University | Graduate Degree | |
United States District Court for the Eastern District of NY | General Government | Corporate Officer/Principal | |
United States District Court for the Southern District of NY | General Government | Corporate Officer/Principal | |
United States Court of Appeals For The Fourth Circuit | Corporate Officer/Principal | ||
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities VC LLC (Frontier Equities) is a venture capital firm founded in 2011 by Mark Sard. The firm is headquartered in New York, United States. | Investment Managers | Founder | |
United States Court of Appeals for the Second Circuit | Corporate Officer/Principal | ||
NUVECTIS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Daniel M. Hume, M.D. PA | President |
Statistiques
Internationale
Etats-Unis | 22 |
Sectorielle
Health Technology | 6 |
Consumer Services | 6 |
Finance | 4 |
Government | 4 |
Commercial Services | 3 |
Opérationnelle
Director/Board Member | 10 |
Corporate Officer/Principal | 9 |
Undergraduate Degree | 4 |
Independent Dir/Board Member | 4 |
Chairman | 2 |
Relations les plus connectées
Insiders | |
---|---|
Daniel Hume | 14 |
Ivan Bergstein | 7 |
Kenneth Hoberman | 6 |
Mark Sard | 4 |
Peter McDonald | 0 |
- Bourse
- Insiders
- Matt Hoberman
- Connexions Sociétés